• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 08/07/2021
Event Type  Injury  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source and the following citation was reviewed: mitsuhashi t, oishi h, makino k, tokugawa j, fuse a, hishii m.Stent-assisted coil embolization for acute ruptured dissecting aneurysm at the p2 segment of the posterior cerebral artery: a case report.J neuroendovasc ther.2022;16(3):157-162.Doi: 10.5797/jnet.Cr.2021-0054.Epub 2021 aug 7.Pmid: 37502277; pmcid: pmc10370781.Section d.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section h.4: the device manufacture date is not known as the device lot number is not available / not reported.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious.The event is reportable to the us fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
This complaint is from a literature source and the following citation was reviewed: mitsuhashi t, oishi h, makino k, tokugawa j, fuse a, hishii m.Stent-assisted coil embolization for acute ruptured dissecting aneurysm at the p2 segment of the posterior cerebral artery: a case report.J neuroendovasc ther.2022;16(3):157-162.Doi: 10.5797/jnet.Cr.2021-0054.Epub 2021 aug 7.Pmid: 37502277; pmcid: pmc10370781.Background and purpose: we report a case of ruptured posterior cerebral artery (pca) dissecting aneurysm treated with stent-assisted coil embolization in the acute phase of ruptured aneurysm.A 60-year-old woman presented with sudden onset of severe headache followed by unconsciousness.Ct showed severe subarachnoid hemorrhage.Digital subtraction angiography showed a dissecting aneurysm at the p2 segment of the right pca.Stent-assisted coil embolization was performed for the ruptured dissecting aneurysm.Since thrombus was observed in the stent, ozagrel was administered intravenously, and the thrombus gradually disappeared during the follow-up period.She was discharged without neurological deficit.Cerenovus devices that were used in this study: qty (b)(4): enterprise stent.Adverse event(s) and provided interventions associated with enterprise stent: qty (b)(4): thrombus formation within stent during procedure, which was treated with intravenous medication.No patient consequence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKENTERPRISE2
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS, INC.
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-689
MDR Report Key18608779
MDR Text Key334141157
Report Number3008114965-2024-00153
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexFemale
-
-